Proteomics and Stem Cell Therapy as a New Vascularization Strategy

NCT02802852 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Critical Limb Ischemia

Interventions

DEVICE: Pneumatic calf compression
DRUG: Filgrastim

Sponsor

University of Illinois at Chicago